NASDAQ:SNBP Sun BioPharma (SNBP) Stock Price, News & Analysis → Stock-Picking AI Predicts #1 Stock of 2024 (From Altimetry) (Ad) Free SNBP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.39▼$0.4850-Day Range$3.45▼$4.5052-Week Range$2.37▼$10.00Volume49,422 shsAverage Volume26,926 shsMarket Capitalization$3.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get Sun BioPharma alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 About Sun BioPharmaSun BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Sun BioPharma, Inc. was founded in 2011 and is based in Waconia, Minnesota.Read More Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 SNBP Stock News HeadlinesApril 29, 2024 | msn.comSun Pharma gets Rs 1.11 crore tax demandApril 16, 2024 | msn.comAnother regulatory blow for Sun Pharma after Dadra unit tagged 'OAI' by US FDA, stock downMay 5, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. April 12, 2024 | msn.comSun Pharma Shares Nosedive 3% After Inspection Notice From FDAApril 12, 2024 | msn.comSun Pharma Slumps Over 2% Early In The Day As Markets Start In RedApril 12, 2024 | msn.comSun Pharma shares trade 3.4% lower following US FDA regulatory actionApril 11, 2024 | msn.comSun Pharma abandons Parkinson's drug trialApril 11, 2024 | msn.comSun Pharma halts trial of its Parkinson’s disease drug as it fails to show “treatment benefits”May 5, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. April 10, 2024 | seekingalpha.comABUS Arbutus Biopharma CorporationMarch 27, 2024 | bbc.co.ukTips for staying safe in the sunMarch 10, 2024 | msn.comSun Pharma recalls 55,000 bottles of generic drug from US market; here's whyMarch 10, 2024 | msn.comSun Pharma recalls 55,000 bottles of generic drug from US market due to manufacturing norms violationJanuary 31, 2024 | msn.comSun Pharma Q3 Results: Net profit rises 16.5% to Rs 2,523.8 croreDecember 17, 2023 | msn.comSun Pharma, Lupin recall drugs in US on manufacturing woesDecember 17, 2023 | msn.comSun Pharma, Lupin recall drugs in US market: USFDANovember 1, 2023 | msn.comSun Pharma Q2 results: Profit rises 5% to Rs 2,376 crore YoY; revenue up 11%November 1, 2023 | reuters.comIndia's top drugmaker Sun Pharma beats Q2 profit viewOctober 27, 2023 | uk.investing.comSun Pharmaceutical Industries Ltd. (SUN)October 8, 2023 | msn.comSun Pharma, Aurobindo recall drugs from US marketOctober 8, 2023 | msn.comSun Pharma, Aurobindo recall drugs from USOctober 4, 2023 | marketwatch.comBiofrontera Says Sun Pharmaceutical Alleging Breach of Contract In LawsuitSeptember 21, 2023 | benzinga.comDebiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-treat CancersSeptember 16, 2023 | msn.comLIC Reduces Stake In Sun Pharma From 5.023% To 3.012%August 28, 2023 | msn.comSun Pharma aims to spend 7-8% of sales on R&DAugust 17, 2023 | marketwatch.comSun Pharmaceutical Industries rises Wednesday, outperforms marketAugust 1, 2023 | marketwatch.comSun Pharmaceutical Industries rises Tuesday, outperforms marketSee More Headlines Receive SNBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sun BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/12/2020Today5/05/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SNBP CUSIPN/A CIKN/A Webwww.sunbiopharma.com Phone952-479-1196FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares9,649,000Free FloatN/AMarket Cap$3.96 million OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Michael T. Cullen Jr. (Age 74)Co-Founder & Exec. Chairman Comp: $282.35kMs. Susan Horvath (Age 61)VP of Fin., CFO, Sec. & Treasurer Comp: $220.31kDr. Jennifer K. Simpson (Age 52)CEO, Pres & Director Dr. Thomas X. NeenanCo-Founder & Chief Scientific OfficerMs. Tammy GroeneVP of OperationsDr. Suzanne Gagnon (Age 63)Chief Medical Officer & Director More ExecutivesKey CompetitorsGT BiopharmaNASDAQ:GTBPSoligenixNASDAQ:SNGXTharimmuneNASDAQ:THARZyVersa TherapeuticsNASDAQ:ZVSALongeveronNASDAQ:LGVNView All Competitors SNBP Stock Analysis - Frequently Asked Questions How were Sun BioPharma's earnings last quarter? Sun BioPharma, Inc. (NASDAQ:SNBP) issued its earnings results on Thursday, November, 12th. The company reported ($0.21) earnings per share for the quarter, missing analysts' consensus estimates of ($0.12) by $0.09. What other stocks do shareholders of Sun BioPharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sun BioPharma investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO). This page (NASDAQ:SNBP) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sun BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
